Key result
Elevated admission hs-cTnI was not independently associated with 30-day mortality in maintenance hemodialysis patients hospitalized with sepsis.
Why the study?
Frequent baseline troponin elevations in asymptomatic ESKD patients complicate interpretation during acute illness, and the prognostic significance of troponin in patients receiving hemodialysis remains uncertain.
Do serial plasma hs-cTnI measurements predict short-term 30-day mortality in patients with end-stage kidney disease on maintenance hemodialysis hospitalized with sepsis?
Observational (n=192)
No
Do serial plasma hs-cTnI measurements predict short-term 30-day mortality in patients with end-stage kidney disease on maintenance hemodialysis hospitalized with sepsis?
Answers are grounded in this paper and cite their sources.
In ESKD patients on maintenance hemodialysis hospitalized for sepsis, hs-cTnI elevation is present in over 85% of cases during the first 24 hours but does not independently predict 30-day mortality, whereas septic shock, hyperlactatemia, and hypoalbuminemia are independent predictors.
BACKGROUNDTroponin is the preferred biomarker for diagnosing acute coronary syndrome.However, in asymptomatic patients with end-stage kidney disease (ESKD), baseline elevations of troponin are common.High-sensitivity cardiac troponin I (hs-cTnI) exceeds the 99 th percentile in approximately 38% of these patients, whereas high-sensitivity cardiac troponin T is elevated in about 68%.This higher prevalence of baseline troponin elevation makes interpretation difficult during acute illness in these patients.Its prognostic significance is still uncertain in patients receiving hemodialysis. AIMTo evaluate serial plasma hs-cTnI levels and their association with short-term mortality among ESKD patients hospitalized with sepsis.
No takes yet. Share an insight, caveat, or question.
Qureshi et al. (2026) conducted an observational in End-stage kidney disease on maintenance hemodialysis hospitalized with sepsis (n=192). Elevated plasma high-sensitivity cardiac troponin I (hs-cTnI > 15.6 pg/mL) at admission vs. Normal plasma hs-cTnI (< 15.6 pg/mL) was evaluated on Short-term (30-day) mortality (OR 1.48, 95% CI 0.58-3.81, p=0.408). Elevated admission hs-cTnI was not independently associated with 30-day mortality in maintenance hemodialysis patients hospitalized with sepsis.
Synapse has enriched 10 related papers. Consider them for comparative context: